DNA Methylation in Aging and Alzheimer's Disease
Raymond Cheng1, Jingmin Shu2, Hai Chen2
1Case Western Reserve University, Cleveland, OH 44106, USA.
Human Brain (Hong Kong)
|June 20, 2025
Summary
Aging alters DNA methylation, impacting Alzheimer's disease (AD) risk. Research highlights global hypomethylation and gene-specific changes, but challenges remain in understanding cell-type specificity and mechanisms.
Area of Science:
- Epigenetics and Aging Research
- Neuroscience and Neurodegenerative Diseases
Background:
- DNA methylation patterns change significantly with age.
- These epigenetic alterations are linked to age-related diseases, notably Alzheimer's disease (AD).
- Global hypomethylation and gene-specific changes in DNA methylation are observed in neurodegeneration.
Purpose of the Study:
- To review current findings on age-related DNA methylation changes in the context of Alzheimer's disease.
- To identify key challenges and unanswered questions in the field.
- To outline future research directions for understanding and potentially treating AD.
Main Methods:
- Analysis of DNA methylome profiling data.
- Review of existing literature on DNA methylation, aging, and Alzheimer's disease.
- Identification of patterns such as global hypomethylation and gene-specific alterations.
Main Results:
- Age-related DNA methylation changes disrupt cellular processes like inflammation and proteostasis, crucial to AD pathology.
- Global hypomethylation, especially in repetitive elements, and gene-specific changes correlate with neurodegeneration.
- Inconsistencies across brain regions and lack of cell-type specificity present interpretation challenges.
Conclusions:
- Understanding the precise mechanisms, cell-type specificity, and functional consequences of DNA methylation changes is critical for AD research.
- Further investigation into spatiotemporal dynamics and cross-tissue correlations is needed.
- Elucidating these epigenetic alterations offers potential for novel therapeutic strategies for AD prevention and treatment.
Related Concept Videos
01:26Alzheimer's Disease: Overview
684
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
684
01:37Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
01:22Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
01:37Mitochondria
15.2K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
15.2K